| 注册
首页|期刊导航|四川医学|唑来膦酸注射液治疗糖尿病骨质疏松患者的疗效研究

唑来膦酸注射液治疗糖尿病骨质疏松患者的疗效研究

王玉容 方向明 叶文春 黄婧 高莉

四川医学Issue(1):69-71,3.
四川医学Issue(1):69-71,3.DOI:10.16252/j.cnki.issn1004-0501-2015.01.022

唑来膦酸注射液治疗糖尿病骨质疏松患者的疗效研究

Clinical Rearch of Zoledronic Acid Treating 55 Diabetic Patients with Osteoporosis

王玉容 1方向明 1叶文春 1黄婧 1高莉1

作者信息

  • 1. 绵阳市中心医院内分泌科,四川 绵阳621000
  • 折叠

摘要

Abstract

Objective To exploring the clinical effect of zoledronic acid( ZOL) treating type 2 diabetic patients with oste-oporosis. Methods Radomly choosing 55 type 2 diabetic patients with osteoporosis in endocrinology department in mianyang cen-tral hospital who were treated by zoledronic acid. To compare the changes of BMD( lumbar spine,femoral neck,femoral greater tro-chanter,faherenheit triangle)、blood Ca、blood P、BGP、B-ALP,Checking the bone syndrome. Results BMD of lumbar spine,fem-oral neck,femoral greater trochanter,faherenheit triangle increased,the difference was statistically significant(P<0. 05),the level of BGP increased,the difference was statistically significant(P<0. 05),the level of BGP discreased,the difference was statistically significant(P<0. 05),the levels of blood Ca and blood P had no change,the difference wasn’t statistically significant(P>0. 05), The bone syndrome changed,the difference was statistically significant(P<0. 05). Conclusion Zoledronic acid treating type 2 diabetic patients with osteoporosis has good effect which is worth promoting.

关键词

唑来膦酸/糖尿病/骨质疏松/骨密度/疗效

Key words

zoledronic acid/diabetes mellitus/osteoporosis/bone syndrome/effect

分类

医药卫生

引用本文复制引用

王玉容,方向明,叶文春,黄婧,高莉..唑来膦酸注射液治疗糖尿病骨质疏松患者的疗效研究[J].四川医学,2015,(1):69-71,3.

四川医学

OACSTPCD

1004-0501

访问量0
|
下载量0
段落导航相关论文